Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Advances in Therapy
Published in: Advances in Therapy 1/2009

01-01-2009 | Original Research

Transmission electron microscopy of VX2 liver tumors after high-intensity focused ultrasound ablation enhanced with SonoVue®

Authors: Qiuyang Li, Junfeng Du, Ming Yu, Guangbin He, Wen Luo, Hongling Li, Xiaodong Zhou

Published in: Advances in Therapy | Issue 1/2009

Login to get access
Metadata
Title
Transmission electron microscopy of VX2 liver tumors after high-intensity focused ultrasound ablation enhanced with SonoVue®
Authors
Qiuyang Li
Junfeng Du
Ming Yu
Guangbin He
Wen Luo
Hongling Li
Xiaodong Zhou
Publication date
01-01-2009
Publisher
Springer Healthcare Communications
Published in
Advances in Therapy / Issue 1/2009
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-008-0126-7

Other articles of this Issue 1/2009

Advances in Therapy 1/2009 Go to the issue

Erratum

Sevikar®: Combination therapy for the treatment of hypertension

Review

Ivabradine: Beyond heart rate control

Review

Testosterone treatment in elderly men

Original Research

Evaluation of the clinical efficacy of conservative treatment in the management of carpal tunnel syndrome

Original Research

Induced apoptosis with ultrasound-mediated microbubble destruction and shRNA targeting survivin in transplanted tumors

Review

Mecasermin (recombinant human insulin-like growth factor I)
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits